{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320554654080.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1681/asn.2005121352"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/00001751-200609000-00030"}},{"identifier":{"@type":"NAID","@value":"30013231222"}}],"dc:title":[{"@value":"Macroalbuminuria Is a Better Risk Marker than Low Estimated GFR to Identify Individuals at Risk for Accelerated GFR Loss in Population Screening"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320554654081","@type":"Researcher","foaf:name":[{"@value":"Nynke Halbesma"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654085","@type":"Researcher","foaf:name":[{"@value":"Dirk-Sjoerd Kuiken"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654084","@type":"Researcher","foaf:name":[{"@value":"Auke H. Brantsma"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654087","@type":"Researcher","foaf:name":[{"@value":"Stephan J.L. Bakker"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654083","@type":"Researcher","foaf:name":[{"@value":"Jack F.M. Wetzels"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654086","@type":"Researcher","foaf:name":[{"@value":"Dick De Zeeuw"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654080","@type":"Researcher","foaf:name":[{"@value":"Paul E. De Jong"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320554654082","@type":"Researcher","foaf:name":[{"@value":"Ronald T. Gansevoort"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10466673"}],"prism:publicationName":[{"@value":"Journal of the American Society of Nephrology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2006-09","prism:volume":"17","prism:number":"9","prism:startingPage":"2582","prism:endingPage":"2590"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/00001751-200609000-00030"}],"createdAt":"2006-08-10","modifiedAt":"2023-04-24","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050282814216502912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease : a population-based cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1050867133849560704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239493324672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166784039040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092685355904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The PKM2 activator TEPP‐46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF‐1α accumulation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118762540928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium–glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin‐overloaded streptozotocin‐induced diabetic mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360847868580084352","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694368234207360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204876689280","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"慢性腎臓病の診断とフォローアップ"},{"@language":"en","@value":"The diagnosis and follow-up of chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390002184888986624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Factors Associated with a Large Decline in Renal Function or Progression to Renal Insufficiency in Hospitalized Atrial Fibrillation Patients with Early-Stage CKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681422130944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"III. Chronic Kidney Diseases and Urinalysis"},{"@language":"ja","@value":"III．慢性腎臓病と検尿"},{"@value":"慢性腎臓病と検尿"},{"@language":"ja-Kana","@value":"マンセイ ジンゾウビョウ ト ケンニョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681422272768","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1. Abnormality in Urinalysis"},{"@language":"ja","@value":"1．検尿異常"},{"@value":"検尿異常"},{"@language":"ja-Kana","@value":"ケンニョウ イジョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750086009216","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"高齢者のCKD診療"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700082338048","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980076183148160","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Very low but stable glomerular filtration rate after living kidney donation : is the concept of \"chronic kidney disease\" applicable to kidney donors?"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261551097141376","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Design and methods of a strategic outcome study for chronic kidney disease : Frontier of Renal Outcome Modifications in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950400957910656","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"evidence-based practice guideline for the treatment of chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231874736561792","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"CKDの意義"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842051128192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Accurate estimation of protein/creatinine ratio on urine sample in CKD patients"}]},{"@id":"https://cir.nii.ac.jp/crid/2051714792004550528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal function trajectory over time and adverse clinical outcomes"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1681/asn.2005121352"},{"@type":"CIA","@value":"30013231222"},{"@type":"CROSSREF","@value":"10.3390/ijms17111800_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1111/jdi.13602_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.2169/naika.96.875_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1038/hr.2012.186_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1038/s41598-018-20874-4_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.2169/naika.97.913_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.4044/joma.120.83_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1111/jdi.13478_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1007/s12199-010-0183-9_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1007/s10157-015-1213-0_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1007/s10157-016-1229-0_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1111/jdi.13760_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1536/ihj.19-205_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"},{"@type":"CROSSREF","@value":"10.1038/s41598-019-43730-5_references_DOI_QQKuj2rptA0Myyavz7x1aDxO5W5"}]}